Valuation: Ainos, Inc.

Market Cap 6.65M 5.92M 5.48M 4.96M 9.35M 627M 9.46M 65.76M 25.8M 330M 24.94M 24.42M 1.05B P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 17.23M 15.35M 14.22M 12.86M 24.24M 1.63B 24.52M 170M 66.88M 855M 64.64M 63.29M 2.72B EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
25.12%
Yield 2024 *
-
Yield 2025 -
1 day-1.43%
1 week-7.56%
Current month-30.13%
1 month-39.22%
3 months-43.12%
6 months-52.80%
Current year-45.89%
1 week 0.8
Extreme 0.8
1.05
1 month 0.8
Extreme 0.8
1.53
Current year 0.8
Extreme 0.8
3.88
1 year 0.8
Extreme 0.8
3.88
3 years 0.8
Extreme 0.8
21.45
5 years 0.8
Extreme 0.8
450
10 years 0.8
Extreme 0.8
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 15/04/2021
Director of Finance/CFO 54 15/03/2024
Director TitleAgeSince
Director/Board Member 49 15/04/2021
Director/Board Member 54 15/04/2021
Director/Board Member 42 15/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
3/6/26 Buy

Director

2,000 0.0286%
28/5/26 Buy

Director

250 0.0036%
27/5/26 Buy

Director

2,000 0.0286%
Change 5-day change 1-year change 3-year change Capi.($)
-1.43%-7.56%-75.59%-94.62% 6.65M
+0.83%+3.52%+24.90%+50.91% 254B
+2.33%+2.23%+4.05%+12.58% 158B
-2.64%+1.34%-7.97%+56.23% 155B
-2.75%+3.40%-55.50%-11.31% 66.06B
-0.21%+7.13%+9.90%+63.25% 51.6B
+0.65%+4.09%-14.18%-11.20% 51.82B
-0.27%+1.83%+15.80%+27.49% 50.89B
+2.19%+2.02%+21.86%+62.36% 48.78B
+2.91%+4.26%+30.34%+78.05% 43.51B
Average +0.15%+1.37%-4.64%+23.37% 87.92B
Weighted average by Cap. +0.27%+3.20%+5.72%+37.98%

Financials

2024 2025
Net sales 20.73K 18.47K 17.1K 15.48K 29.16K 1.96M 29.5K 205K 80.46K 1.03M 77.76K 76.14K 3.28M 124K 111K 102K 92.7K 175K 11.72M 177K 1.23M 482K 6.16M 466K 456K 19.62M
Net income -14.86M -13.24M -12.26M -11.1M -20.91M -1.4B -21.15M -147M -57.69M -737M -55.76M -54.6M -2.35B -14.77M -13.16M -12.19M -11.03M -20.78M -1.39B -21.02M -146M -57.33M -733M -55.41M -54.26M -2.33B
Net Debt 8.11M 7.22M 6.69M 6.05M 11.4M 765M 11.54M 80.19M 31.47M 402M 30.41M 29.78M 1.28B 10.58M 9.43M 8.73M 7.9M 14.89M 999M 15.06M 105M 41.07M 525M 39.7M 38.87M 1.67B
Projected Income Statement - Annual - Ainos, Inc.
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
22/10/26 US$0.8874 -1.43% 17,914
20/10/26 US$0.9003 -3.35% 10,200
19/10/26 US$0.9315 +0.83% 73,986
16/10/26 US$0.9238 -3.77% 15,670
15/10/26 US$0.9600 0.00% 68,992
  1. Stock Market
  2. Stocks
  3. AIMD Stock